Wutah dodolan YoY sajrone 12 wulan kepungkur: sonomapharma.com (SNOA)

Tandha merek Sonoma Pharmaceuticals Inc. (SNOA)

This rolling 12-month YoY revenue growth chart demonstrates demand dynamics, where the 39.00 mark indicates the level of current purchasing power for Sonoma Pharmaceuticals (SNOA). Niche protection is ensured by CE and FDA certifications, as well as patents for wound-healing formulations. Stable cash flow and margins are supported by the unique Microcyn technology. However, business success depends on dermatologist approval and the cost of chemical raw materials.

Wutah dodolan YoY sajrone rolas wulan kepungkur Sonoma Pharmaceuticals (SNOA): kanggo periode 11.02.2024 - 19.11.2026

Sonoma Pharmaceuticals - rincian analitis lan metrik utama (SNOA)

- nilai pasar lan prakiraan target analis:
Analisis kabeh metrik perusahaan:sonomapharma.com, SNOA
Produk asli Sonoma Pharma

Professional managers utilize fundamental metrics to filter assets, assessing business expansion rates through rolling year revenue dynamics. This LTM (Last Twelve Months) trading income growth metric measures the speed of cash inflows, which is critical for Sonoma Pharmaceuticals (SNOA) due to its total dependence on the production stability of external CMOs while managing marketing independently.